Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

globenewswire.com
KODK Listed as a key company in the Age-related Macular Degeneration Market report, highlighting its presence in the AMD therapeutics space. RKDA Appears in multiple AMD market reports (Age-related Macular Degeneration Market, Dry Age-related Macular Degeneration Market, Wet Age-related Macular Degeneration Market, Geographic Atrophy Market), indicating significant involvement in AMD treatments. OTLK Listed as a key company in the Age-related Macular Degeneration Market report, indicating its role in the AMD therapeutics landscape. UTHR Mentioned as a key company in the Age-related Macular Degeneration Market report, highlighting its involvement in AMD drug development. CLSD Appears in both the Age-related Macular Degeneration Market and Wet Age-related Macular Degeneration Market reports as a key company in AMD treatments. AZN Listed as a key company in the Age-related Macular Degeneration Market report, highlighting its involvement in AMD drug development. BTE Appears in multiple AMD market reports (Age-related Macular Degeneration Market, Dry Age-related Macular Degeneration Market, Geographic Atrophy Market), indicating its role in AMD treatments. CCNE Mentioned in the Age-related Macular Degeneration Market, Dry Age-related Macular Degeneration Market, and Geographic Atrophy Market reports as a key company in AMD treatments. IONS Appears in both the Age-related Macular Degeneration Market and Geographic Atrophy Market reports as a key company in AMD treatments. APLS Mentioned in both the Age-related Macular Degeneration Market and Geographic Atrophy Market reports as a key company in AMD treatments. GYRO Listed as a key company in the Age-related Macular Degeneration Market report, indicating its involvement in AMD therapeutics. NVS Mentioned in multiple AMD market reports (Age-related Macular Degeneration Market, Wet Age-related Macular Degeneration Market, Geographic Atrophy Market), indicating its significant role in AMD treatments. GNTX Listed as a key company in the Age-related Macular Degeneration Market report, highlighting its involvement in AMD drug development. BLTE Mentioned as a key company in the Dry Age-related Macular Degeneration Market report, indicating its role in AMD therapeutics. JNJ Mentioned as a key company in the Dry Age-related Macular Degeneration Market report, indicating its presence in the AMD therapeutics sector. LCTX Mentioned in the Dry Age-related Macular Degeneration Market report (via CellCure Neurosciences) and Geographic Atrophy Market report, indicating its role in AMD treatments. ABBV Listed as a key company in the Wet Age-related Macular Degeneration Market report, indicating its presence in the AMD therapeutics sector. REGN Mentioned as a key company in the Wet Age-related Macular Degeneration Market report, indicating its role in AMD drug development.

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape New York, USA, June 18, 2026 (GLOBE NEWSWIRE) -- Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

The age-related macular degeneration clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline age-related macular degeneration drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

DelveInsight’s 'Age-related Macular Degeneration Pipeline Insight 2026' report provides comprehensive global coverage of pipeline therapies for age-related macular degeneration across various stages of clinical development. The report offers an in-depth analysis of key trends, emerging therapies, and competitive landscape dynamics, highlighting the strategies of major pharmaceutical companies to advance the pipeline and capitalize on future growth opportunities. In addition, it includes critical insights into clinical trial benchmarking, partnering and licensing activities, and regulatory pathways involving the FDA and EMA, enabling stakeholders to make informed decisions and optimize development strategies within the age-related macular degeneration domain.

Age-related Macular Degeneration Clinical Trial Analysis Summary

Request a sample and discover the recent advances in age-related macular degeneration drug development @ https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight

What is Age-related Macular Degeneration?

Age-related macular degeneration (AMD) is a progressive eye condition that primarily affects older adults and leads to the deterioration of the macula, the central part of the retina responsible for sharp, detailed vision. As the disease advances, it can cause blurred or distorted central vision, making everyday tasks such as reading, recognizing faces, and driving increasingly difficult, while peripheral vision typically remains intact. AMD is broadly classified into two types: dry, which is more common and progresses gradually due to the accumulation of drusen deposits, and wet, a less common but more severe form characterized by abnormal blood vessel growth and leakage beneath the retina. Risk factors include aging, genetic predisposition, smoking, and lifestyle factors, and although there is no cure, early detection and appropriate management can help slow disease progression and preserve vision.

Find out more about age-related macular degeneration drug development @ Age-related Macular Degeneration Treatment

A snapshot of the Pipeline Age-related Macular Degeneration Drugs mentioned in the report:

Learn more about the emerging age-related macular degeneration therapies @ Age-related Macular Degeneration Clinical Trials

As per Stuti Mahajan, consulting manager at DelveInsight, the AMD market is driven by the growing elderly population, increasing disease prevalence, and rising demand for durable vision-preserving therapies with reduced injection burden. At the same time, next-generation biologics, gene therapies, complement inhibitors, and sustained-delivery technologies are advancing the AMD landscape beyond traditional anti-VEGF treatment approaches.

Recent Developments in Age-related Macular Degeneration Treatment Space

Scope of the Age-related Macular Degeneration Pipeline Report

Dive deep into rich insights for new age-related macular degeneration treatments, visit @ Age-related Macular Degeneration Drugs

Table of Contents

For further information on the age-related macular degeneration cure research, reach out @ Medication for Age-related Macular Degeneration Treatment

Related Reports

Age-related Macular Degeneration Market

Age-related Macular Degeneration Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key AMD companies, including Opthea Limited, Kodiak Sciences Inc., REGENXBIO, Alkahest Inc, Evergreen Therapeutics, Alkeus Pharmaceuticals, Ribomic USA Inc, Outlook Therapeutics, Inc., Unity Biotechnology, Inc, PanOptica, Inc., Clearside Biomedical, Alexion Pharmaceuticals, AstraZeneca, Alkeus Pharmaceuticals, Stealth BioTherapeutics, CellCure Neurosciences, Regenerative Patch Technologies, Allegro Ophthalmics, Annexon Biosciences, NGM Biopharmaceuticals, Ionis Pharmaceuticals, Apellis Pharmaceuticals, Iveric Bio, Gyroscope Therapeutics, Novartis, Luxa Biotechnology, Gemini Therapeutics, and others.

Dry Age-related Macular Degeneration Market

Dry Age-related Macular Degeneration Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key dry AMD companies including Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Annexon Biosciences, and others.

Wet Age-related Macular Degeneration Market

Wet Age-related Macular Degeneration Market Insight, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key wet AMD companies, including Adverum Biotechnologies, Regenxbio, AbbVie, Ocugenix, Alkahest, Ribomic USA, 4D Molecular Therapeutics, AffaMed Therapeutics, Clearside Biomedical, Caregen, Elisigen, NexThera, Ashvattha Therapeutics, Avirmax Biopharma, Roche, Novartis, Regeneron Pharmaceuticals, Bayer, and others.

Wet AMD Clinical Trial Analysis

Wet AMD Pipeline Insight – 2026 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key wet AMD companies, including Sylentis, Molecular Partners, Sam Chun Dang Pharm, Generium, Alvotech, Adverum Biotechnologies, EyePoint Pharmaceuticals, 4D Molecular Therapeutics, OliX Pharmaceuticals, Kyowa Kirin, Exonate, and others.

Geographic Atrophy Market

Geographic Atrophy Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key geographic atrophy companies, including Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Regenerative Patch Technologies, Novartis, Roche, Ionis Pharmaceuticals, CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics), and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.